Correlation Between ATyr Pharma and Arcellx
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Arcellx, you can compare the effects of market volatilities on ATyr Pharma and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Arcellx.
Diversification Opportunities for ATyr Pharma and Arcellx
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between ATyr and Arcellx is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Arcellx go up and down completely randomly.
Pair Corralation between ATyr Pharma and Arcellx
If you would invest 7,037 in Arcellx on September 5, 2024 and sell it today you would earn a total of 1,548 from holding Arcellx or generate 22.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
ATyr Pharma vs. Arcellx
Performance |
| Timeline |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Arcellx |
ATyr Pharma and Arcellx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATyr Pharma and Arcellx
The main advantage of trading using opposite ATyr Pharma and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
| Arcellx vs. Candel Therapeutics | Arcellx vs. Cingulate Warrants | Arcellx vs. Unicycive Therapeutics | Arcellx vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world |